Sensus Healthcare, Inc. Line of Credit Facility, Maximum Amount Outstanding During Period
Sensus Healthcare, Inc. (SRTS) reported Line of Credit Facility, Maximum Amount Outstanding During Period of $15.00 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Notes › Line of Credit Facility
us-gaap:LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod · last filed 2024-11-14
- 2024-09-30: Line of Credit Facility, Maximum Amount Outstanding During Period 9 month $15.00M.
| Period end | Line of Credit Facility, Maximum Amount Outstanding During Period 9 month |
|---|---|
| 2024-09-30 | $15.00M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |